Skip to main content
Log in

Celsior Versus University of Wisconsin Preserving Solutions for Liver Transplantation: Postreperfusion Syndrome and Outcome of a 5-Year Prospective Randomized Controlled Study

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Celsior solution (CS) is a high-sodium, low-potassium, low-viscosity extracellular solution that has been used for liver graft preservation in recent years, although experience with it is still limited. We performed an open-label randomized active-controlled trial comparing CS with the University of Wisconsin solution (UW) for liver transplantation (LT), with a follow-up period of 5 years.

Methods

Adult transplant recipients (n = 102) were prospectively randomized to receive either CS (n = 51) or UW (n = 51). The two groups were comparable with respect to donor and recipient characteristics. The primary outcome measure was the incidence of postreperfusion syndrome (PRS). Secondary outcome measures included primary nonfunction (PNF) or primary dysfunction (PDF), liver retransplantation, and graft and patient survival. Other secondary outcome measures were days in the intensive care unit (ICU) and the rates of acute rejection, chronic rejection, infectious complications, postoperative reoperations, and vascular and biliary complications.

Results

In all, 14 posttransplant variables revealed no significant differences between the groups. There were no cases of PNF or PDF. The incidence of PRS was 5.9% in the CS group and 21.6% in the UW group (P = 0.041). After reperfusion, CS revealed greater control of serum potassium (P = 0.015), magnesium levels (P = 0.005), and plasma glucose (P = 0.042) than UW. Respective patient survivals at 3, 12, and 60 months were 95.7, 87.2, and 82.0% for the CS group and 95.7, 83.3, and 66.6% for the UW group (P = 0.123).

Conclusions

While retaining the same degree of safety and effectiveness as UW for LT, CS may yield postliver graft reperfusion benefits, as shown in this study by a significant reduction in the incidence of PRS and greater metabolic control.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Benichou J, Halgrimson CG, Weil R et al (1977) Canine and human liver preservation for 6–18 hours by cold infusion. Transplantation 24:407–411

    Article  PubMed  CAS  Google Scholar 

  2. Kalayoglu M, Sollinger HW, Stratta RJ et al (1988) Extended preservation of the liver for clinical transplantation. Lancet 1:617–619

    PubMed  CAS  Google Scholar 

  3. Belzer FO (1989) Clinical organ preservation with UW solution. Transplantation 47:1097–1098

    Article  PubMed  CAS  Google Scholar 

  4. Todo S, Nery J, Yanaga K et al (1989) Extended preservation of human liver grafts with UW solution. JAMA 261:711–714

    Article  PubMed  CAS  Google Scholar 

  5. Cofer JB, Klintmalm GB, Howard TK et al (1990) A comparison of UW with Eurocollins preservation solution in liver transplantation. Transplantation 49:1088–1093

    Article  PubMed  CAS  Google Scholar 

  6. Belzer FO, D’Alessandro AM, Hoffmann RM et al (1992) The use of UW solution in clinical transplantation. A 4-year experience. Ann Surg 215:579–583

    Article  PubMed  CAS  Google Scholar 

  7. Abu-Elmagd K, Fung J, Bueno J et al (2000) Logistics and technique for procurement of intestinal, pancreatic, and hepatic grafts from de same donor. Ann Surg 232:680–687

    Article  PubMed  CAS  Google Scholar 

  8. Menasche P, Pradier F, Grousset C et al (1993) Improved recovery of heart transplants with a specific kit of preservation solutions. J Thorac Cardiovasc Surg 105:353–363

    PubMed  CAS  Google Scholar 

  9. Menasché P, Termignon JL, Pradier F et al (1994) Experimental evaluation of Celsior, a new heart preservation solution. Eur J Cardiothorac Surg 8:207–213

    Article  PubMed  Google Scholar 

  10. Vega JD, Ochsner JL, Jeevanandam V et al (2001) A multicenter, randomized, controlled trial of Celsior for flush and hypothermic storage of cardiac allografts. Ann Thorac Surg 71:1442–1447

    Article  PubMed  CAS  Google Scholar 

  11. Michel P, Vial R, Rodriguez C et al (2002) A comparative study of the most widely used solutions for cardiac graft preservation during hypothermia. J Heart Lung Transplant 21:1030–1039

    Article  PubMed  Google Scholar 

  12. Remadi JP, Baron O, Roussel JC et al (2002) Myocardial preservation using Celsior solution in cardiac transplantation: early results and 5-year follow-up of a multicenter prospective study of 70 cardiac transplantations. Ann Thorac Surg 73:1495–1499

    Article  PubMed  Google Scholar 

  13. De Santo LS, Amarelli C, Romano G et al (2006) High-risk heart grafts: effective preservation with Celsior solution. Heart Vessels 21:89–94

    Article  PubMed  Google Scholar 

  14. Thabut G, Vinatier I, Brugiere O et al (2001) Influence of preservation solution on early graft failure in clinical lung transplantation. Am J Respir Crit Care Med 164:1204–1208

    PubMed  CAS  Google Scholar 

  15. Baron O, Fabre S, Haloun A et al (2002) Retrospective clinical comparison of Celsior solution to modified blood Wallwork solution in lung transplantation for cystic fibrosis. Prog Transplant 12:176–180

    PubMed  CAS  Google Scholar 

  16. Faenza A, Catena F, Nardo B et al (2001) Kidney preservation with University of Wisconsin and Celsior solution: a prospective multicenter randomized study. Transplantation 72:1274–1277

    Article  PubMed  Google Scholar 

  17. Cavallari A, Cillo U, Nardo B et al (2003) A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation. Liver Transpl 9:814–821

    Article  PubMed  Google Scholar 

  18. Boggi U, Vistoli F, Del Chiaro M et al (2004) Pancreas preservation with University of Wisconsin and Celsior solutions: a single center, prospective randomized study. Transplantation 77:1186–1190

    Article  PubMed  CAS  Google Scholar 

  19. Karam G, Compagnon P, Hourmant M et al (2005) A single solution for multiple organ procurement and preservation. Transpl Int 18:657–663

    Article  PubMed  Google Scholar 

  20. Aggarwal S, Kang Y, Freeman J et al (1993) Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver. J Crit Care 17:154–160

    Article  Google Scholar 

  21. Aggarwal S, Kang Y, Freeman JA et al (1987) Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplant Proc 19(Suppl 3):54–55

    PubMed  CAS  Google Scholar 

  22. Ploeg RJ, D’Alessandro AM, Knechtle SJ et al (1993) Risk factors for primary dysfunction after liver transplantation—a multivariate analysis. Transplantation 55:807–813

    Article  PubMed  CAS  Google Scholar 

  23. Belzer FO, Southard JH (1988) Principles of solid-organ preservation by cold storage. Transplantation 45:673–676

    Article  PubMed  Google Scholar 

  24. Pedotti P, Cardillo M, Rigotti P et al (2004) A comparative prospective study of two available solutions for kidney and liver preservation. Transplantation 77:1540–1545

    Article  PubMed  Google Scholar 

  25. Nardo B, Bertelli R, Montalti R et al (2005) Preliminary results of a clinical randomized study comparing Celsior and HTK solutions in liver preservation for transplantation. Transplant Proc 37:320–322

    Article  PubMed  CAS  Google Scholar 

  26. Prien T, Dietl KH, Zander J et al (1989) Bradyarrhythmia with University of Wisconsin preservation solution. Lancet 1:1319–1320

    Article  PubMed  CAS  Google Scholar 

  27. Ramsay M (2008) The reperfusion syndrome: Have we made any progress? Liver Transpl 14:412–414

    Article  PubMed  Google Scholar 

  28. Garutti Martinez I, Olmedilla L, Perez-Peña JM et al (1997) Response to clamping of the inferior vena cava as a factor for predicting postreperfusion syndrome during liver transplantation. Anesth Analg 84:254–259

    PubMed  CAS  Google Scholar 

  29. Nanashima A, Pillay P, Crawford M et al (2001) Analysis of postrevascularization syndrome after orthotopic liver transplantation: the experience of an Australian liver transplantation center. J Hepatobiliary Pancreat Surg 8:557–563

    Article  PubMed  CAS  Google Scholar 

  30. Ayanoglu HO, Ulukaya S, Tokat Y (2003) Causes of postreperfusion syndrome in living or cadaveric donor liver transplantations. Transplant Proc 35:1442–1444

    Article  PubMed  CAS  Google Scholar 

  31. Moreno C, Sabaté A, Figueras J et al (2006) Hemodynamic profile and tissular oxygenation in orthotopic liver transplantation: influence of hepatic artery or portal vein revascularization of the graft. Liver Transpl 12:1607–1614

    Article  PubMed  Google Scholar 

  32. Hilmi I, Horton CN, Planinsic RM et al (2008) The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation. Liver Transpl 14:504–508

    Article  PubMed  Google Scholar 

  33. Nakasuji M, Bookallil MJ (2000) Pathophysiological mechanisms of postrevascularization hyperkalemia in orthotopic liver transplantation. Anesth Analg 91:1351–1355

    Article  PubMed  CAS  Google Scholar 

  34. Xia VW, Ghobrial RM, Du B et al (2007) Predictors of hyperkalemia in the prereperfusion, early postreperfusion, and late postreperfusion periods during adult liver transplantation. Anesth Analg 105:780–785

    Article  PubMed  Google Scholar 

  35. Scott VL, De Wolf AM, Kang Y et al (1996) Ionized hypomagnesemia in patients undergoing orthotopic liver transplantation: a complication of citrate intoxication. Liver Transpl Surg 2:343–347

    Article  PubMed  CAS  Google Scholar 

  36. Lopez-Andujar R, Deusa S, Montalvá E et al (2009) Comparative prospective study of two liver graft preservation solutions: University of Wisconsin and Celsior. Liver Transpl 15:1709–1717

    Article  PubMed  Google Scholar 

  37. Koneru B, Sterling MJ, Bahramipour PF (2006) Bile duct strictures after liver transplantation: a changing landscape of the Achilles’ heel. Liver Transpl 12:702–704

    Article  PubMed  Google Scholar 

  38. Moench C, Moench K, Lohse AW et al (2003) Prevention of ischemic-type biliary lesions by arterial back-table pressure perfusion. Liver Transpl 9:285–289

    Article  PubMed  Google Scholar 

  39. Eghtesad B, Aucejo F, Fung JJ (2006) Preservation solutions in liver transplantation: what are the options? Liver Transp 12:196–198

    Article  Google Scholar 

  40. Puhl G, Olschewski P, Schöning W et al (2006) Low viscosity Histidine-Tryptophan-Ketoglutarate graft flush improves subsequent extended cold storage in University of Wisconsin solution in an extracorporeal rat liver perfusion and rat liver transplantation model. Liver Transpl 12:1841–1849

    Article  PubMed  Google Scholar 

  41. Lama C, Rafecas A, Figueras J et al (2002) Comparative study of Celsior and Belzer solutions for hepatic graft preservation: preliminary results. Transplant Proc 34:54–55

    Article  PubMed  CAS  Google Scholar 

  42. Adam R, McMaster P, O’Grady JG et al (2003) Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl 9:1231–1243

    Article  PubMed  Google Scholar 

  43. Pfitzmann R, Benscheidt B, Langrehr JM et al (2007) Trends and experiences in liver retransplantation over 15 years. Liver Transpl 13:248–257

    Article  PubMed  Google Scholar 

  44. Yamauchi Y, Wettergren A, Yamashita Y et al (2007) Retransplantation of the liver in adults: long-term outcome and prognostic modeling. Hepatogastroenterology 54:1181–1186

    PubMed  Google Scholar 

  45. Gustafsson BI, Backman L, Friman S et al (2006) Retransplantation of the liver. Transplant Proc 38:1438–1439

    Article  PubMed  CAS  Google Scholar 

  46. Jain A, Reyes J, Kashyap R et al (2000) Long-term survival after liver transplantation in 4000 consecutive patients at a single center. Ann Surg 232:490–500

    Article  PubMed  CAS  Google Scholar 

  47. Busuttil RW, Farmer DG, Yersiz H et al (2005) Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg 241:905–916

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Gobierno de Aragón (grants B40 and PI036/09) and by F.I.S. from Instituto de Salud Carlos III (grant RD06/0013/1017).

Conflict of interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francisco A. García-Gil.

Rights and permissions

Reprints and permissions

About this article

Cite this article

García-Gil, F.A., Serrano, M.T., Fuentes-Broto, L. et al. Celsior Versus University of Wisconsin Preserving Solutions for Liver Transplantation: Postreperfusion Syndrome and Outcome of a 5-Year Prospective Randomized Controlled Study. World J Surg 35, 1598–1607 (2011). https://doi.org/10.1007/s00268-011-1078-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-011-1078-7

Keywords

Navigation